Head-to-head · Cost-Efficiency Index
Kina vs Novi
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Kina
Cost-first shoppers who want perimenopausal/menopausal women wanting GLP-1 weight management bundled with HRT and other menopause-specific care under one named clinical lead.
Visit KinaNovi
Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site.
Visit NoviThe verdict
Kina and Novi tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Kina (ranked #103, a hair above #105) — Cost-first shoppers who want perimenopausal/menopausal women wanting GLP-1 weight management bundled with HRT and other menopause-specific care under one named clinical lead. But Novi is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Kina.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Kina | Novi |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $169/mo (all doses, compounded) | $99/mo (all doses, promotional rate, compounded) |
| Tirzepatide / mo | $249/mo (compounded) | $133/mo (all doses, promotional rate, compounded) |
| Semaglutide / yr (modeled) | $2,028 | $1,188 |
| Tirzepatide / yr (modeled) | $2,988 | $1,596 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #103 | #105 |
Kina
69/100Where the value is
- Names an actual clinical lead (Dr. Shannon Arora, PharmD) tied to a real affiliated practice with an address
- LegitScript badge confirmed with verification link
- Consultation/physician-review fee is bundled into the price rather than charged separately
The tradeoffs
- $169 headline price is a first-month-only discount; true ongoing price is $199/mo
- Not a dedicated GLP-1 company -- weight/GLP-1 is one of six categories on a menopause-focused platform
Novi
69/100Where the value is
- Lowest advertised entry price in this entire batch for both drugs ($99 semaglutide / $133 tirzepatide)
- LegitScript certified, independently verifiable via the linked legitscript.com record
- States one flat price per dose with no separate visit fee and free shipping
The tradeoffs
- No published mg dose, supply duration, state-coverage list, named medical director, or named compounding pharmacy anywhere on the site or its help center — the least transparent operational disclosure of any company researched in this batch
- The advertised $99/$133 rate is displayed against a live countdown timer ('price increases in...') next to a claimed $299 original price, a scarcity tactic that makes it unclear whether this is a genuine standing rate or a recurring promotional one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.